Literature DB >> 23740962

Understanding the expectations of patients with inherited retinal dystrophies.

Ryan Combs1, Georgina Hall, Katherine Payne, Jo Lowndes, Sophie Devery, Susan M Downes, Anthony T Moore, Simon Ramsden, Graeme C M Black, Marion McAllister.   

Abstract

BACKGROUND: UK genetic ophthalmology services for patients with retinal dystrophy (RD) are variable. Little research exists to define service requirements, or expectations, of patients and their families. This study aimed to explore the views and perceived benefits of genetic ophthalmology services among members of families with RD.
METHODS: Twenty participants with known RD mutations were recruited through UK genetic ophthalmic clinics. Semistructured qualitative interviews explored interviewees' perceptions of the role of these services. Interviews were transcribed verbatim and analysed using inductive thematic analysis.
RESULTS: Interviewees' expectations and requirements of genetic ophthalmology services were wide-ranging and often perceived to be unmet. Participant expectations were classified in three groups: (1) Medical expectations included obtaining a diagnosis and information about disease/prognosis, genetic risks and research (2) Psychosocial expectations related to participants' need for support in adjusting to RD (3) Practical expectations included the desire for information about welfare and support.
CONCLUSIONS: Expectations of RD families for clinical services are complex, encompassing a range of healthcare specialties. Services that align to these expectations will need to reach beyond the diagnostic arena and provide practical and psychosocial support. The identification of measurable outcomes will facilitate future development and evaluation of service delivery models. Many of the expectations identified here map to an existing, previously validated, outcomes framework for clinical genetic services. However, an additional outcome domain, labelled 'Independence' was also identified; this could either be specific to vision loss or relate generally to disability caused by genetic conditions.

Entities:  

Keywords:  Dystrophy; Genetics; Retina; Treatment other

Mesh:

Year:  2013        PMID: 23740962     DOI: 10.1136/bjophthalmol-2012-302911

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Seeing through their eyes: lived experiences of people with retinitis pigmentosa.

Authors:  M Prem Senthil; J Khadka; K Pesudovs
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

2.  Variation in healthcare services for specialist genetic testing and implications for planning genetic services: the example of inherited retinal dystrophy in the English NHS.

Authors:  Mark Harrison; Stephen Birch; Martin Eden; Simon Ramsden; Tracey Farragher; Katherine Payne; Georgina Hall; Graeme Cm Black
Journal:  J Community Genet       Date:  2015-01-09

3.  Identifying variation in models of care for the genomic-based diagnosis of inherited retinal dystrophies in the United Kingdom.

Authors:  M Eden; K Payne; C Jones; S J Wright; G Hall; M McAllister; G Black
Journal:  Eye (Lond)       Date:  2016-04-15       Impact factor: 3.775

4.  Patient expectations and attitudes towards specialist genetic eye services.

Authors:  E Clarke; R Combs; G Black; G Hall
Journal:  J Genet Couns       Date:  2014-10-03       Impact factor: 2.537

5.  Current understanding of genetics and genetic testing and information needs and preferences of adults with inherited retinal disease.

Authors:  Martin McKibbin; Mushtaq Ahmed; Matthew J Allsop; Louise Downey; Richard Gale; Hilary Louise Grant; Barbara Potrata; Thomas A Willis; Jenny Hewison
Journal:  Eur J Hum Genet       Date:  2014-01-08       Impact factor: 4.246

6.  The economic case for precision medicine.

Authors:  Sean P Gavan; Alexander J Thompson; Katherine Payne
Journal:  Expert Rev Precis Med Drug Dev       Date:  2018-01-08

7.  Vision-related quality of life in adults with severe peripheral vision loss: a qualitative interview study.

Authors:  Ryan Lange; Abigail Kumagai; Sara Weiss; Katherine B Zaffke; Sherry Day; Donna Wicker; Ashley Howson; K Thiran Jayasundera; Lori Smolinski; Christina Hedlich; Paul P Lee; Robert W Massof; Joan A Stelmack; Noelle E Carlozzi; Joshua R Ehrlich
Journal:  J Patient Rep Outcomes       Date:  2021-01-13

8.  Target 5000: a standardized all-Ireland pathway for the diagnosis and management of inherited retinal degenerations.

Authors:  Kirk A J Stephenson; Julia Zhu; Niamh Wynne; Adrian Dockery; Rebecca M Cairns; Emma Duignan; Laura Whelan; Conor P Malone; Hilary Dempsey; Karen Collins; Shana Routledge; Rajiv Pandey; Elaine Crossan; Jacqueline Turner; James J O'Byrne; Laura Brady; Giuliana Silvestri; Paul F Kenna; G Jane Farrar; David J Keegan
Journal:  Orphanet J Rare Dis       Date:  2021-05-05       Impact factor: 4.123

9.  Collaborative Research and Development of a Novel, Patient-Centered Digital Platform (MyEyeSite) for Rare Inherited Retinal Disease Data: Acceptability and Feasibility Study.

Authors:  Rose M Gilbert; Dayyanah Sumodhee; Nikolas Pontikos; Catherine Hollyhead; Angus Patrick; Samuel Scarles; Sabrina Van Der Smissen; Rodrigo M Young; Nick Nettleton; Andrew R Webster; Jocelyn Cammack
Journal:  JMIR Form Res       Date:  2022-01-31

10.  Exploring the feasibility of delivering standardized genomic care using ophthalmology as an example.

Authors:  Niall Davison; Katherine Payne; Martin Eden; Marion McAllister; Stephen A Roberts; Stuart Ingram; Graeme C M Black; Georgina Hall
Journal:  Genet Med       Date:  2017-03-16       Impact factor: 8.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.